227 related articles for article (PubMed ID: 32349103)
1. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography manifestations of primary vitreoretinal lymphoma.
Saito T; Ohguro N; Iwahashi C; Hashida N
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2319-2326. PubMed ID: 27251192
[TBL] [Abstract][Full Text] [Related]
3. PERIVASCULAR FLOWER-BUD-LIKE LESIONS ON EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH VITREORETINAL LYMPHOMA.
Chen W; Gu J; Liu S; Zhao Z; Jiang T; Xu G; Chang Q
Retina; 2022 Nov; 42(11):2169-2175. PubMed ID: 35982514
[TBL] [Abstract][Full Text] [Related]
4. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
Zhao H; Wang X; Mao Y; Peng X
BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
[TBL] [Abstract][Full Text] [Related]
6. Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate.
Jiang T; Gu J; Liu S; Chang Q
BMC Ophthalmol; 2022 Sep; 22(1):375. PubMed ID: 36127675
[TBL] [Abstract][Full Text] [Related]
7. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
[TBL] [Abstract][Full Text] [Related]
8. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
9. ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA.
Lavine JA; Singh AD; Sharma S; Baynes K; Lowder CY; Srivastava SK
Retina; 2019 Oct; 39(10):1861-1871. PubMed ID: 30044267
[TBL] [Abstract][Full Text] [Related]
10. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.
Cicinelli MV; Marchese A; Miserocchi E; Giuffré C; Berchicci L; Querques G; Bandello F; Modorati GM
Ocul Immunol Inflamm; 2020 May; 28(4):637-646. PubMed ID: 31393199
[TBL] [Abstract][Full Text] [Related]
11. Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.
Balaratnasingam C; Messinger JD; Sloan KR; Yannuzzi LA; Freund KB; Curcio CA
Ophthalmology; 2017 May; 124(5):644-656. PubMed ID: 28153442
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma.
Pang CE; Shields CL; Jumper JM; Yannuzzi LA
Am J Ophthalmol; 2014 Dec; 158(6):1253-1261.e2. PubMed ID: 25174893
[TBL] [Abstract][Full Text] [Related]
13. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
14. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.
Deák GG; Goldstein DA; Zhou M; Fawzi AA; Jampol LM
JAMA Ophthalmol; 2019 Feb; 137(2):194-198. PubMed ID: 30489610
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
[TBL] [Abstract][Full Text] [Related]
16. En Face Optical Coherence Tomography Angiography of Primary Vitreoretinal Lymphoma.
Pierro L; Arrigo A; Casalino G; Miserocchi E; Aragona E; Bandello F
Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):e173-e174. PubMed ID: 30395684
[TBL] [Abstract][Full Text] [Related]
17. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
18. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
[TBL] [Abstract][Full Text] [Related]
19. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
[TBL] [Abstract][Full Text] [Related]
20. Lifecycles of Individual Subretinal Drusenoid Deposits and Evolution of Outer Retinal Atrophy in Age-Related Macular Degeneration.
Zhang Y; Wang X; Sadda SR; Clark ME; Witherspoon CD; Spaide RF; Owsley C; Curcio CA
Ophthalmol Retina; 2020 Mar; 4(3):274-283. PubMed ID: 31924545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
